The covid 19 vaccine developer Pfizer and its German partner BioNTech SE has already got approval in the US, UK, Singapore. They made a request to ministry of health in Japan for the approval today. The expected availability of vaccine is March 2021.
The Pfizer-BioNTech vaccine is projected to be delivered in batches of 1,000 doses but they need to be stored at minus 75 C or lower and administered within approximately 10 days.
If approved by the authorities, vaccinations could begin in Japan in March 2021, government officials said. Japan has already agreed with Pfizer to receive a supply of 120 million doses in the first half of next year, enough for 60 million people, or roughly half of the population.
“We will strictly screen the effectiveness and safety (of the vaccine) before making a judgment,” Health, Labor and Welfare Minister Norihisa Tamura told a news conference.
Akihisa Harada, president of the Japan unit of Pfizer, said the company wants to help get life back to normal.
“In the event that we win approval, we would like to ensure a fast delivery of our vaccine to people in Japan and play a part in normalizing their social life,” he said.
The company is seeking fast-track approval without having to conduct large-scale trials on the basis that the vaccine has been approved in other countries.
It has already conducted clinical trials involving 160 people in Japan, aiming to report the results to authorities by February.
Source: JapanTimes 20201218 9:58 PM